- Home
- POOL vs QGEN Comparison
POOL vs QGEN Comparison
Compare POOL & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POOL
- QGEN
- Stock Information
- Founded
- POOL 1993
- QGEN 1986
- Country
- POOL United States
- QGEN Netherlands
- Employees
- POOL N/A
- QGEN N/A
- Industry
- POOL Industrial Specialties
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- POOL Consumer Discretionary
- QGEN Health Care
- Exchange
- POOL Nasdaq
- QGEN Nasdaq
- Market Cap
- POOL 11.6B
- QGEN 10.7B
- IPO Year
- POOL 1995
- QGEN 1996
- Fundamental
- Price
- POOL $247.68
- QGEN $43.18
- Analyst Decision
- POOL Hold
- QGEN Buy
- Analyst Count
- POOL 9
- QGEN 7
- Target Price
- POOL $338.33
- QGEN $50.68
- AVG Volume (30 Days)
- POOL 799.9K
- QGEN 1.2M
- Earning Date
- POOL 10-23-2025
- QGEN 11-04-2025
- Dividend Yield
- POOL 2.01%
- QGEN 3.43%
- EPS Growth
- POOL N/A
- QGEN 334.36
- EPS
- POOL 10.93
- QGEN 1.85
- Revenue
- POOL $5,294,666,000.00
- QGEN $2,070,781,000.00
- Revenue This Year
- POOL $1.92
- QGEN $7.37
- Revenue Next Year
- POOL $3.55
- QGEN $5.65
- P/E Ratio
- POOL $22.73
- QGEN $23.78
- Revenue Growth
- POOL N/A
- QGEN 5.32
- 52 Week Low
- POOL $242.10
- QGEN $37.63
- 52 Week High
- POOL $395.60
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- POOL 17.52
- QGEN 27.38
- Support Level
- POOL $290.23
- QGEN $43.26
- Resistance Level
- POOL $305.58
- QGEN $47.39
- Average True Range (ATR)
- POOL 8.59
- QGEN 1.09
- MACD
- POOL -3.98
- QGEN -0.60
- Stochastic Oscillator
- POOL 8.78
- QGEN 3.10
About POOL Pool Corporation
Pool Corp distributes swimming pool supplies and related products. Its products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).